JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Riluzole (formerly PK26124, RP54274, RP-54274, PK-26124; Rilutek), an anticonvulsant of the Na+ channel blocker class, is a glutamate release inhibitor with neuroprotective, anticonvulsant, anxiolytic and anesthetic activities. Riluzole has been approved as a medication to treat amyotrophic lateral sclerosis. Riluzole acts by complex mechanism involving inhibition of voltage-dependent Na channels, high-voltage activated Ca and K channels, and inhibition of protein kinase C. It was suggested that this mechanism was involved in antioxidative processes.
References: Neurology. 1996 Dec; 47(6 Suppl 4):S233-41; Naunyn-Schmiedeberg's Archives of Pharmacology
Chemical Name: 6-(trifluoromethoxy)-1, 3-benzothiazol-2-amine
InChi Key: FTALBRSUTCGOEG-UHFFFAOYSA-N
InChi Code: InChI=1S/C8H5F3N2OS/c9-8(10, 11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H, (H2, 12, 13)
SMILES: NC1=NC2=CC=C(OC(F)(F)F)C=C2S1
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!